Posts by admin
How to Choose a Compounding Pharmacy for Peptides: Quality Markers, Red Flags, and Questions to Ask
Why Selection Matters
The compounding pharmacy you partner with is not interchangeable with any other pharmacy that advertises compoun...
Which USP Chapters Are Enforceable by Law? A Compliance Prime
The Short Answer
USP chapters numbered below 1000 are generally enforceable standards under federal law. USP chapters numbered 1000 an...
USP 795, 797, 800 Explained: What Every Compounding Pharmacy Partner Should Demonstrate
Why USP Standards Matter for Prescribers
When a physician writes a prescription to a compounding pharmacy, the quality of the dispense...
FDA-Approved Peptides List 2026: A Physician’s Regulatory Landscape
Why a Consolidated View Matters
The peptide regulatory landscape is not organized in a way that's easy for practicing physicians to na...
503A vs 503B Compounding Pharmacies: Which One Your Practice Needs
The Core Distinction
503A and 503B are sections of the federal Drug Quality and Security Act that define two different categories of c...
PCAC July 2026 Meeting: What Physicians Should Watch for on Compounding Peptides
Why PCAC Matters
The Pharmacy Compounding Advisory Committee (PCAC) is the FDA advisory body that evaluates substances for potential i...
The FDA 503A Bulk Drug Substances List: Current Peptide Status (April 2026 Update)
Why This Post Matters
The FDA's April 2026 action on the 503A bulk drug substances list — specifically the peptide substances — was on...
Natural GLP-1 Support: Supplements and Peptide Alternatives for Weight Management
Setting Expectations
"Natural GLP-1 support" is a search phrase that reflects a patient audience looking for alternatives to prescript...
Compounded Tirzepatide in 2026: Sourcing, Legality, and What to Tell Patients
The Shifting Landscape
The compounded tirzepatide landscape has evolved substantially. During documented shortages of FDA-approved tir...
Semaglutide vs Tirzepatide vs Retatrutide: Weight Loss Percentages and Mechanisms Compared
Three Compounds, Three Receptor Profiles
The incretin class has expanded rapidly. Semaglutide, tirzepatide, and retatrutide represent ...